The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Real-time PCR Instruments and Reagents Market Research Report 2025

Global Real-time PCR Instruments and Reagents Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1898814

No of Pages : 102

Ask Your Query
Synopsis
In conventional PCR, the amplified DNA product, or amplicon, is detected in an end-point analysis. In real-time PCR, the accumulation of amplification product is measured as the reaction progresses, in real time, with product quantification after each cycle. The main advantage of real-time PCR over PCR is that real-time PCR allows you to determine the initial number of copies of template DNA (the amplification target sequence) with accuracy and high sensitivity over a wide dynamic range. Real-time PCR results can either be qualitative (the presence or absence of a sequence) or quantitative (copy number). Quantitative real-time PCR is thus also known as qPCR analysis. In contrast, PCR is at best semiquantitative. Additionally, real-time qPCR data can be evaluated without gelelectrophoresis, resulting in reduced bench time and increased throughput. Finally, because real-time qPCR reactions are run and data are evaluated in a unified, closed-tube qPCR system, opportunities for contamination are reduced and the need for postamplification manipulation is eliminated in qPCR analysis.
The global Real-time PCR Instruments and Reagents market was valued at US$ 4281 million in 2023 and is anticipated to reach US$ 10800 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
In Middle East, key players of real-time PCR instruments and reagents include Bioeksen R&D Technologies, Sansure Biotech, Thermo Fisher Scientific, etc. The top three players hold a share about 34%. Egypt is the largest market in Middle East, has around 27% share, followed by Turkey and Saudi Arabia, with about 25% and 18% share, respectively.
This report aims to provide a comprehensive presentation of the global market for Real-time PCR Instruments and Reagents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Real-time PCR Instruments and Reagents.
Report Scope
The Real-time PCR Instruments and Reagents market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Real-time PCR Instruments and Reagents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Real-time PCR Instruments and Reagents companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Roche
DaAn Gene
Sansure Biotech
QIAGEN
Bio-Rad
Biosynex
Cepheid
Hangzhou Bloer Technology
Liferiver Bio-Tech
Xi'an Tianlong Science and Technology
Bioperfectus Technologies
BGI Group
Agilent Technologies
Hybribio
Shanghai Biogerm Medical
Shanghai Hongshi Medical Technology
Suzhou Molarray
Merck
Analytik Jena
Takara
Meridian Life Science
Promega Corporation
Segment by Type
Reagent
Instrument
Segment by Application
Infectious Disease
Prenatal and Postnatal Care
Cancer Screening and Treatment
Organ Transplant
Individual Identification
Agriculture
Customs Quarantine
Food Safety
Forensic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Real-time PCR Instruments and Reagents companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Real-time PCR Instruments and Reagents Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Reagent
1.2.3 Instrument
1.3 Market by Application
1.3.1 Global Real-time PCR Instruments and Reagents Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Infectious Disease
1.3.3 Prenatal and Postnatal Care
1.3.4 Cancer Screening and Treatment
1.3.5 Organ Transplant
1.3.6 Individual Identification
1.3.7 Agriculture
1.3.8 Customs Quarantine
1.3.9 Food Safety
1.3.10 Forensic
1.3.11 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Real-time PCR Instruments and Reagents Market Perspective (2019-2030)
2.2 Real-time PCR Instruments and Reagents Growth Trends by Region
2.2.1 Global Real-time PCR Instruments and Reagents Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Real-time PCR Instruments and Reagents Historic Market Size by Region (2019-2024)
2.2.3 Real-time PCR Instruments and Reagents Forecasted Market Size by Region (2025-2030)
2.3 Real-time PCR Instruments and Reagents Market Dynamics
2.3.1 Real-time PCR Instruments and Reagents Industry Trends
2.3.2 Real-time PCR Instruments and Reagents Market Drivers
2.3.3 Real-time PCR Instruments and Reagents Market Challenges
2.3.4 Real-time PCR Instruments and Reagents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Real-time PCR Instruments and Reagents Players by Revenue
3.1.1 Global Top Real-time PCR Instruments and Reagents Players by Revenue (2019-2024)
3.1.2 Global Real-time PCR Instruments and Reagents Revenue Market Share by Players (2019-2024)
3.2 Global Real-time PCR Instruments and Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Real-time PCR Instruments and Reagents Revenue
3.4 Global Real-time PCR Instruments and Reagents Market Concentration Ratio
3.4.1 Global Real-time PCR Instruments and Reagents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Real-time PCR Instruments and Reagents Revenue in 2023
3.5 Real-time PCR Instruments and Reagents Key Players Head office and Area Served
3.6 Key Players Real-time PCR Instruments and Reagents Product Solution and Service
3.7 Date of Enter into Real-time PCR Instruments and Reagents Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Real-time PCR Instruments and Reagents Breakdown Data by Type
4.1 Global Real-time PCR Instruments and Reagents Historic Market Size by Type (2019-2024)
4.2 Global Real-time PCR Instruments and Reagents Forecasted Market Size by Type (2025-2030)
5 Real-time PCR Instruments and Reagents Breakdown Data by Application
5.1 Global Real-time PCR Instruments and Reagents Historic Market Size by Application (2019-2024)
5.2 Global Real-time PCR Instruments and Reagents Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Real-time PCR Instruments and Reagents Market Size (2019-2030)
6.2 North America Real-time PCR Instruments and Reagents Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Real-time PCR Instruments and Reagents Market Size by Country (2019-2024)
6.4 North America Real-time PCR Instruments and Reagents Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Real-time PCR Instruments and Reagents Market Size (2019-2030)
7.2 Europe Real-time PCR Instruments and Reagents Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Real-time PCR Instruments and Reagents Market Size by Country (2019-2024)
7.4 Europe Real-time PCR Instruments and Reagents Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Real-time PCR Instruments and Reagents Market Size (2019-2030)
8.2 Asia-Pacific Real-time PCR Instruments and Reagents Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Real-time PCR Instruments and Reagents Market Size by Region (2019-2024)
8.4 Asia-Pacific Real-time PCR Instruments and Reagents Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Real-time PCR Instruments and Reagents Market Size (2019-2030)
9.2 Latin America Real-time PCR Instruments and Reagents Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Real-time PCR Instruments and Reagents Market Size by Country (2019-2024)
9.4 Latin America Real-time PCR Instruments and Reagents Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Real-time PCR Instruments and Reagents Market Size (2019-2030)
10.2 Middle East & Africa Real-time PCR Instruments and Reagents Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Real-time PCR Instruments and Reagents Market Size by Country (2019-2024)
10.4 Middle East & Africa Real-time PCR Instruments and Reagents Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Real-time PCR Instruments and Reagents Introduction
11.1.4 Thermo Fisher Scientific Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Real-time PCR Instruments and Reagents Introduction
11.2.4 Roche Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.2.5 Roche Recent Development
11.3 DaAn Gene
11.3.1 DaAn Gene Company Detail
11.3.2 DaAn Gene Business Overview
11.3.3 DaAn Gene Real-time PCR Instruments and Reagents Introduction
11.3.4 DaAn Gene Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.3.5 DaAn Gene Recent Development
11.4 Sansure Biotech
11.4.1 Sansure Biotech Company Detail
11.4.2 Sansure Biotech Business Overview
11.4.3 Sansure Biotech Real-time PCR Instruments and Reagents Introduction
11.4.4 Sansure Biotech Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.4.5 Sansure Biotech Recent Development
11.5 QIAGEN
11.5.1 QIAGEN Company Detail
11.5.2 QIAGEN Business Overview
11.5.3 QIAGEN Real-time PCR Instruments and Reagents Introduction
11.5.4 QIAGEN Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.5.5 QIAGEN Recent Development
11.6 Bio-Rad
11.6.1 Bio-Rad Company Detail
11.6.2 Bio-Rad Business Overview
11.6.3 Bio-Rad Real-time PCR Instruments and Reagents Introduction
11.6.4 Bio-Rad Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.6.5 Bio-Rad Recent Development
11.7 Biosynex
11.7.1 Biosynex Company Detail
11.7.2 Biosynex Business Overview
11.7.3 Biosynex Real-time PCR Instruments and Reagents Introduction
11.7.4 Biosynex Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.7.5 Biosynex Recent Development
11.8 Cepheid
11.8.1 Cepheid Company Detail
11.8.2 Cepheid Business Overview
11.8.3 Cepheid Real-time PCR Instruments and Reagents Introduction
11.8.4 Cepheid Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.8.5 Cepheid Recent Development
11.9 Hangzhou Bloer Technology
11.9.1 Hangzhou Bloer Technology Company Detail
11.9.2 Hangzhou Bloer Technology Business Overview
11.9.3 Hangzhou Bloer Technology Real-time PCR Instruments and Reagents Introduction
11.9.4 Hangzhou Bloer Technology Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.9.5 Hangzhou Bloer Technology Recent Development
11.10 Liferiver Bio-Tech
11.10.1 Liferiver Bio-Tech Company Detail
11.10.2 Liferiver Bio-Tech Business Overview
11.10.3 Liferiver Bio-Tech Real-time PCR Instruments and Reagents Introduction
11.10.4 Liferiver Bio-Tech Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.10.5 Liferiver Bio-Tech Recent Development
11.11 Xi'an Tianlong Science and Technology
11.11.1 Xi'an Tianlong Science and Technology Company Detail
11.11.2 Xi'an Tianlong Science and Technology Business Overview
11.11.3 Xi'an Tianlong Science and Technology Real-time PCR Instruments and Reagents Introduction
11.11.4 Xi'an Tianlong Science and Technology Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.11.5 Xi'an Tianlong Science and Technology Recent Development
11.12 Bioperfectus Technologies
11.12.1 Bioperfectus Technologies Company Detail
11.12.2 Bioperfectus Technologies Business Overview
11.12.3 Bioperfectus Technologies Real-time PCR Instruments and Reagents Introduction
11.12.4 Bioperfectus Technologies Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.12.5 Bioperfectus Technologies Recent Development
11.13 BGI Group
11.13.1 BGI Group Company Detail
11.13.2 BGI Group Business Overview
11.13.3 BGI Group Real-time PCR Instruments and Reagents Introduction
11.13.4 BGI Group Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.13.5 BGI Group Recent Development
11.14 Agilent Technologies
11.14.1 Agilent Technologies Company Detail
11.14.2 Agilent Technologies Business Overview
11.14.3 Agilent Technologies Real-time PCR Instruments and Reagents Introduction
11.14.4 Agilent Technologies Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.14.5 Agilent Technologies Recent Development
11.15 Hybribio
11.15.1 Hybribio Company Detail
11.15.2 Hybribio Business Overview
11.15.3 Hybribio Real-time PCR Instruments and Reagents Introduction
11.15.4 Hybribio Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.15.5 Hybribio Recent Development
11.16 Shanghai Biogerm Medical
11.16.1 Shanghai Biogerm Medical Company Detail
11.16.2 Shanghai Biogerm Medical Business Overview
11.16.3 Shanghai Biogerm Medical Real-time PCR Instruments and Reagents Introduction
11.16.4 Shanghai Biogerm Medical Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.16.5 Shanghai Biogerm Medical Recent Development
11.17 Shanghai Hongshi Medical Technology
11.17.1 Shanghai Hongshi Medical Technology Company Detail
11.17.2 Shanghai Hongshi Medical Technology Business Overview
11.17.3 Shanghai Hongshi Medical Technology Real-time PCR Instruments and Reagents Introduction
11.17.4 Shanghai Hongshi Medical Technology Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.17.5 Shanghai Hongshi Medical Technology Recent Development
11.18 Suzhou Molarray
11.18.1 Suzhou Molarray Company Detail
11.18.2 Suzhou Molarray Business Overview
11.18.3 Suzhou Molarray Real-time PCR Instruments and Reagents Introduction
11.18.4 Suzhou Molarray Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.18.5 Suzhou Molarray Recent Development
11.19 Merck
11.19.1 Merck Company Detail
11.19.2 Merck Business Overview
11.19.3 Merck Real-time PCR Instruments and Reagents Introduction
11.19.4 Merck Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.19.5 Merck Recent Development
11.20 Analytik Jena
11.20.1 Analytik Jena Company Detail
11.20.2 Analytik Jena Business Overview
11.20.3 Analytik Jena Real-time PCR Instruments and Reagents Introduction
11.20.4 Analytik Jena Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.20.5 Analytik Jena Recent Development
11.21 Takara
11.21.1 Takara Company Detail
11.21.2 Takara Business Overview
11.21.3 Takara Real-time PCR Instruments and Reagents Introduction
11.21.4 Takara Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.21.5 Takara Recent Development
11.22 Meridian Life Science
11.22.1 Meridian Life Science Company Detail
11.22.2 Meridian Life Science Business Overview
11.22.3 Meridian Life Science Real-time PCR Instruments and Reagents Introduction
11.22.4 Meridian Life Science Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.22.5 Meridian Life Science Recent Development
11.23 Promega Corporation
11.23.1 Promega Corporation Company Detail
11.23.2 Promega Corporation Business Overview
11.23.3 Promega Corporation Real-time PCR Instruments and Reagents Introduction
11.23.4 Promega Corporation Revenue in Real-time PCR Instruments and Reagents Business (2019-2024)
11.23.5 Promega Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock
This site is protected by VikingCloud's Trusted Commerce program